The timing of liver transplantation after primary hepatectomy for hepatocellular carcinoma: A special reference to recurrence pattern and milan criteria

Transplantation

Volumn 86, Issue 5, 2008, Pages 641-646

  Ikegami, Toru ^a   Shimada, Mitsuo ^a   Imura, Satoru ^a   Yoshizumi, Tomoharu ^a   Arakawa, Yusuke ^a   Tokunaga, Takuya ^a   Morine, Yuji ^a   Kanemura, Hirofumi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Hepatic resection; Hepatocellular carcinoma; Liver transplantation; Milan criteria

Indexed keywords

ANTINEOPLASTIC AGENT; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT CANCER; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME; DISEASE FREE SURVIVAL; ITALY; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; MORTALITY; PATIENT SELECTION; RECURRENT DISEASE; SURVIVAL; TIME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; HEPATECTOMY; HUMANS; ITALY; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MIDDLE AGED; PATIENT SELECTION; RECURRENCE; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 53449088350     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181814de2     Document Type: Article

References (32)

1. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatmentofsmall hepatocellular carcinomas inpatients with cirrhosis. N Engl J Med 1996; 334: 693.
2. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocel-lular carcinoma: Comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002; 8: 765.
3. Todo S, Furukawa H, Japanese Study Group on Organ Transplantation. Living donor liver transplantation for adult patients with hepato-cellular carcinoma: Experience in Japan. Ann Surg 2004; 240: 451.
4. Nagasue N, Kohno H, Chang YC, et al. Liver resection for hepatocel-lular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg 1993; 217: 375.
5. Taura K, Ikai I, Hatano E, et al. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: An analysis of 293 patients. Surgery 2007; 142: 685.
6. De Carlis L, Giacomoni A, Pirotta V, et al. Surgical treatment of hepa-tocellular cancer in the era of hepatic transplantation. J Am Coll Surg 2003; 196: 887.
7. Poon RT, Fan ST, Lo CM, et al. Long-term survival and pattern of recurrence after resection ofsmall hepatocellular carcinoma inpatients with preserved liver function: Implications for a strategy of salvage transplantation. Ann Surg 2002; 235: 373.
8. BelghitiJ,CortesA, Abdalla EK,et al. Resection priortoliver transplantation for hepatocellular carcinoma. Ann Surg 2003; 238: 885.
9. Margarit C, Escartn A, Castells L, et al. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl 2005; 11: 1242.
10. Poon RT. Optimal initial treatment for early hepatocellular carcinoma in patients with preserved liver function: Transplantation or resection? Ann Surg Oncol 2007; 14: 541.
11. Yao FY, Hirose R, LaBerge JM, et al. A prospective study on downstag-ing of hepatocellular carcinoma prior to liver transplantation. Liver Transpl 2005; 11: 1505.
12. Graziadei IW, Sandmueller H, Waldenberger P, et al. Chemoemboli-zation followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 2003; 9: 557.
13. Mazzaferro V, Battiston C, Perrone S, et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: A prospective study. Ann Surg 2004; 240: 900.
14. Yao FY, KinkhabwalaM,LaBerge JM,et al. The impactofpre-operative loco-regional therapy on outcome after liver transplantation for hepa-tocellular carcinoma. Am J Transplant 2005; 5: 795.
15. Hasegawa K, Kokudo N, Imamura H, et al. Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 2005; 242: 252.
16. Arii S,Yamaoka Y,FutagawaS,et al. Results ofsurgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000; 32: 1224.
17. Nakazawa T, Kokubu S, Shibuya A, et al. Radiofrequency ablation of hepatocellular carcinoma: Correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol 2007; 188: 480.
18. Harada N, ShimadaM, Okano S,et al. IL-12 gene therapy is aneffective therapeutic strategy for hepatocellular carcinoma in immunosup-pressed mice. J Immunol 2004; 173: 6635.
19. Vivarelli M, Bellusci R, Cucchetti A, et al. Low recurrence rate of hep-atocellular carcinoma after liver transplantation: Better patient selection or lower immunosuppression? Transplantation 2002; 74: 1746.
20. Majno P, Giostra E, Morel P, et al. Management of hepatocellular carcinoma in the waiting list before liver transplantation. J Hepatol 2005; 42: S134.
21. Majno P, Mentha G, Mazzaferro V. Resection, transplantation, either, or both? Other pieces of the puzzle. Liver Transpl 2005; 11: 1177.
22. Hwang S, Lee SG, Moon DB, et al. Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma. Liver Transpl 2007; 13: 741.
23. Pawlik TM, Delman KA, Vauthey JN, et al. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 2005; 11: 1086.
24. McPeake JR, O'Grady JG, Zaman S, et al. Liver transplantation for primary hepatocellular carcinoma: Tumor size and number determine outcome. J Hepatol 1993 Jun; 18: 226.
25. Soejima Y, Taketomi A, Yoshizumi T, et al. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation 2007; 83: 893.
26. Takada Y, Ueda M, Ito T, et al. Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma. Liver Transpl 2006; 12: 912.
27. Adam R, Azoulay D, Castaing D, et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: A reasonable strategy? Ann Surg 2003; 238: 508.
28. Shimada M, Yonemura Y, Ijichi H, et al. Living donor liver transplantation for hepatocellular carcinoma: A special reference to a preoperative des-gamma-carboxy prothrombin value. Transplant Proc 2005; 37: 1177.
29. Shimada M, Takenaka K, Fujiwara Y, et al. Des-gamma-carboxy pro-thrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma. Cancer 1996; 78: 2094.
30. Sala M, Fuster J, Llovet JM, et al. High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: An indication for salvage liver transplantation. Liver Transpl 2004; 10: 1294.
31. Lang H, Sotiropoulos GC, Brokalaki EI, et al. Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers. J Am Coll Surg 2007; 205: 27.
32. Yamashita Y, Taketomi A, Itoh S, et al. Long-term favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience. J Am Coll Surg 2007; 205: 19.